MAGNESIUM CITRATE

MAGNESIUM CITRATE was reported 6294 times

MAGNESIUM CITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMA SITE DERMATITIS 11 0.3333
1 HYPOCHOLESTEROLAEMIA 84 0.2380
2 OBSTRUCTIVE DEFAECATION 11 0.1642
3 HEPATIC ENZYME 19 0.1275
4 FACET JOINT SYNDROME 336 0.1031
5 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 11 0.0759
6 RHEUMATIC FEVER 335 0.0751
7 PERIPHERAL VENOUS DISEASE 299 0.0731
8 ONYCHOMADESIS 296 0.0705
9 DISLOCATION OF VERTEBRA 137 0.0600
10 ONYCHOMYCOSIS 256 0.0583
11 BLEPHAROSPASM 361 0.0573
12 LUPUS VULGARIS 65 0.0516
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 106 0.0511
14 BURKHOLDERIA TEST POSITIVE 6 0.0484
15 BREAST CANCER STAGE III 311 0.0480
16 RETINITIS 80 0.0463
17 DEEP VEIN THROMBOSIS POSTOPERATIVE 90 0.0449
18 SWOLLEN JOINT COUNT INCREASED 143 0.0448
19 VISUAL SNOW SYNDROME 8 0.0430
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 308 0.0429
21 DUODENAL ULCER PERFORATION 310 0.0416
22 C-REACTIVE PROTEIN ABNORMAL 267 0.0416
23 ANTICIPATORY ANXIETY 11 0.0404
24 SERONEGATIVE ARTHRITIS 42 0.0366
25 X-RAY ABNORMAL 64 0.0358
26 CONVULSIONS LOCAL 7 0.0354
27 FINGER DEFORMITY 160 0.0330
28 FOLLICULITIS 346 0.0330
29 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 18 0.0321
30 MUSCLE INJURY 265 0.0320
31 LIP DRY 288 0.0317
32 PEMPHIGUS 395 0.0316
33 GRIP STRENGTH DECREASED 264 0.0300
34 HYPERCHOLESTEROLAEMIA 282 0.0292
35 NAIL DISORDER 252 0.0288
36 HELICOBACTER INFECTION 291 0.0283
37 SWOLLEN JOINT COUNT 7 0.0280
38 BURSITIS 335 0.0276
39 INFUSION SITE REACTION 80 0.0268
40 LIVE BIRTH 218 0.0260
41 JOINT RANGE OF MOTION DECREASED 329 0.0245
42 PERICARDITIS 411 0.0244
43 C-REACTIVE PROTEIN 22 0.0237
44 RHEUMATOID FACTOR POSITIVE 137 0.0237
45 CONGENITAL ANOMALY 180 0.0232
46 PORPHYRIA ACUTE 33 0.0230
47 OVERLAP SYNDROME 16 0.0229
48 PRODUCT LABEL CONFUSION 133 0.0228
49 WOUND INFECTION 242 0.0221
50 BACK INJURY 240 0.0220
51 SYNOVITIS 397 0.0220
52 GRIP STRENGTH 5 0.0218
53 HAND DEFORMITY 282 0.0215
54 BONE EROSION 76 0.0215
55 TASTE DISORDER 350 0.0172
56 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 11 0.0165
57 IRRITABLE BOWEL SYNDROME 349 0.0163
58 STOMA SITE INFLAMMATION 12 0.0161
59 GLOSSODYNIA 349 0.0156
60 OBESITY 247 0.0155
61 WOUND 412 0.0147
62 FIBROMYALGIA 356 0.0146
63 COELIAC DISEASE 143 0.0146
64 NERVE BLOCK 8 0.0137
65 PRODUCT CONTAMINATION MICROBIAL 16 0.0134
66 CONTRAINDICATED PRODUCT ADMINISTERED 400 0.0132
67 SPONDYLITIS 48 0.0132
68 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 21 0.0131
69 DRUG TOLERANCE 63 0.0124
70 LIVER INJURY 304 0.0124
71 HYPERMAGNESAEMIA 8 0.0123
72 DRUG TOLERANCE DECREASED 33 0.0117
73 EXOSTOSIS 103 0.0113
74 NORMAL NEWBORN 61 0.0112
75 TYPE 2 DIABETES MELLITUS 374 0.0111
76 EPILEPSY 336 0.0110
77 RED BLOOD CELL SEDIMENTATION RATE INCREASED 120 0.0108
78 GASTRIC VARICES 5 0.0106
79 IMPAIRED HEALING 347 0.0106
80 NIGHT SWEATS 338 0.0105
81 FAECAL VOLUME DECREASED 5 0.0104
82 PSORIATIC ARTHROPATHY 420 0.0103
83 C-REACTIVE PROTEIN INCREASED 375 0.0103
84 ADVERSE REACTION 135 0.0102
85 SYSTEMIC LUPUS ERYTHEMATOSUS 360 0.0101
86 RHONCHI 14 0.0101
87 LIVER FUNCTION TEST INCREASED 217 0.0101
88 ULCER HAEMORRHAGE 68 0.0100
89 BREAST CANCER STAGE II 76 0.0091
90 AUTOIMMUNE DISORDER 87 0.0089
91 PRURITUS ALLERGIC 10 0.0086
92 BLOOD CHOLESTEROL INCREASED 396 0.0085
93 SEIZURE CLUSTER 7 0.0084
94 THERAPEUTIC PRODUCT EFFECT DECREASED 377 0.0084
95 GASTROINTESTINAL BACTERIAL OVERGROWTH 5 0.0083
96 STOMA SITE PAIN 12 0.0082
97 GAIT INABILITY 272 0.0081
98 RECALLED PRODUCT ADMINISTERED 75 0.0079
99 PRESCRIBED OVERDOSE 149 0.0077
100 TETANY 14 0.0077
101 OSTEOARTHRITIS 308 0.0073
102 GASTROINTESTINAL STOMA COMPLICATION 11 0.0070
103 CERUMEN IMPACTION 6 0.0066
104 INFUSION RELATED REACTION 430 0.0065
105 BLOOD UREA DECREASED 8 0.0064
106 LUNG DISORDER 309 0.0063
107 LOWER RESPIRATORY TRACT INFECTION 286 0.0063
108 LUPUS-LIKE SYNDROME 57 0.0063
109 INFLAMMATION 323 0.0063
110 EXCESSIVE GRANULATION TISSUE 5 0.0062
111 GASTROOESOPHAGEAL REFLUX DISEASE 499 0.0062
112 BLISTER 340 0.0060
113 SLEEP DISORDER 417 0.0059
114 HEPATITIS 151 0.0059
115 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 100 0.0058
116 HEPATIC ENZYME INCREASED 397 0.0058
117 SCIATICA 92 0.0058
118 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
119 WALKING AID USER 37 0.0056
120 UNDERWEIGHT 11 0.0056
121 BLOOD MAGNESIUM INCREASED 5 0.0055
122 PRESCRIBED UNDERDOSE 110 0.0055
123 DRUG-INDUCED LIVER INJURY 170 0.0054
124 CORTISOL DECREASED 6 0.0052
125 ILL-DEFINED DISORDER 319 0.0052
126 ARTHROPATHY 291 0.0052
127 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 12 0.0052
128 RECALLED PRODUCT 9 0.0052
129 WHEEZING 308 0.0052
130 FAECES HARD 20 0.0051
131 DRY MOUTH 412 0.0051
132 MOBILITY DECREASED 360 0.0050
133 BODY TEMPERATURE ABNORMAL 9 0.0049
134 LUMBAR VERTEBRAL FRACTURE 22 0.0048
135 PULMONARY FIBROSIS 92 0.0048
136 MIGRAINE 455 0.0048
137 INJURY 333 0.0047
138 TREATMENT FAILURE 392 0.0047
139 MALLORY-WEISS SYNDROME 6 0.0047
140 STOMATITIS 285 0.0047
141 PUSTULAR PSORIASIS 16 0.0047
142 EAR PAIN 90 0.0046
143 EYE INJURY 14 0.0046
144 MATERNAL EXPOSURE TIMING UNSPECIFIED 17 0.0045
145 JOINT DESTRUCTION 7 0.0045
146 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
147 MUSCULOSKELETAL PAIN 232 0.0044
148 HEPATIC CIRRHOSIS 82 0.0044
149 INTENTIONAL PRODUCT USE ISSUE 379 0.0043
150 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 28 0.0043
151 MATERNAL EXPOSURE DURING PREGNANCY 379 0.0042
152 EXPOSURE DURING PREGNANCY 264 0.0042
153 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
154 SWELLING 388 0.0041
155 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
156 LUMBAR SPINAL STENOSIS 12 0.0041
157 COMPLEX REGIONAL PAIN SYNDROME 6 0.0041
158 NECK PAIN 225 0.0040
159 LOWER LIMB FRACTURE 77 0.0040
160 NEURITIS 6 0.0039
161 EYE ALLERGY 6 0.0039
162 COSTOCHONDRITIS 6 0.0037
163 INJECTION SITE REACTION 249 0.0036
164 RHEUMATOID ARTHRITIS 409 0.0036
165 DELIRIUM 125 0.0036
166 EARLY SATIETY 7 0.0036
167 JOINT SWELLING 425 0.0035
168 DRUG INTOLERANCE 340 0.0035
169 RASH VESICULAR 17 0.0035
170 SPINAL FUSION SURGERY 14 0.0034
171 DYSPEPSIA 337 0.0034
172 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 241 0.0034
173 GENERAL PHYSICAL HEALTH DETERIORATION 390 0.0034
174 OPHTHALMIC HERPES ZOSTER 6 0.0033
175 NEPHROGENIC ANAEMIA 15 0.0032
176 MUSCULOSKELETAL STIFFNESS 281 0.0032
177 FREQUENT BOWEL MOVEMENTS 86 0.0032
178 JOINT STIFFNESS 83 0.0032
179 MEMORY IMPAIRMENT 427 0.0031
180 NASAL SEPTUM DEVIATION 6 0.0031
181 GASTROINTESTINAL DISORDER 275 0.0031
182 OEDEMA 166 0.0031
183 BLOOD MAGNESIUM DECREASED 26 0.0030
184 MENOPAUSAL SYMPTOMS 7 0.0030
185 COMPRESSION FRACTURE 16 0.0030
186 VARICES OESOPHAGEAL 9 0.0030
187 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 142 0.0030
188 EYELID PAIN 6 0.0029
189 FOOD AVERSION 5 0.0029
190 CONFUSIONAL STATE 476 0.0029
191 JOINT DISLOCATION 31 0.0029
192 ABDOMINAL DISTENSION 306 0.0029
193 LONG QT SYNDROME 7 0.0029
194 PERIPHERAL SWELLING 446 0.0029
195 PRE-EXISTING CONDITION IMPROVED 18 0.0029
196 DISCOMFORT 171 0.0028
197 HYPERAESTHESIA 23 0.0028
198 ABDOMINAL DISCOMFORT 458 0.0027
199 MENOPAUSE 7 0.0027
200 THERAPY NON-RESPONDER 122 0.0027
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
202 MUSCLE SPASMS 481 0.0026
203 FOOT DEFORMITY 29 0.0026
204 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 44 0.0026
205 ATROPHY 5 0.0026
206 MUSCULAR WEAKNESS 291 0.0026
207 HYPOAESTHESIA 380 0.0025
208 TENOSYNOVITIS 7 0.0025
209 ABDOMINAL PAIN UPPER 521 0.0025
210 PRODUCT QUALITY ISSUE 342 0.0025
211 BRAIN FOG 39 0.0025
212 PARAESTHESIA 388 0.0025
213 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
214 DEVICE INFUSION ISSUE 6 0.0024
215 DRUG USE DISORDER 20 0.0024
216 BOWEL MOVEMENT IRREGULARITY 18 0.0023
217 TENDERNESS 24 0.0023
218 URINE OUTPUT INCREASED 6 0.0023
219 OSTEOPOROSIS 94 0.0023
220 DEFAECATION URGENCY 16 0.0023
221 GENERAL SYMPTOM 17 0.0023
222 FAECES PALE 5 0.0022
223 PRODUCT CONTAMINATION 8 0.0022
224 WHITE BLOOD CELL DISORDER 6 0.0022
225 MYOSITIS 20 0.0022
226 INFUSION SITE PRURITUS 7 0.0022
227 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
228 TRIGGER FINGER 9 0.0022
229 TIC 12 0.0022
230 HICCUPS 18 0.0022
231 FAECALOMA 12 0.0022
232 GASTROINTESTINAL PAIN 24 0.0022
233 RESPIRATORY DISORDER 65 0.0022
234 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
235 HIP ARTHROPLASTY 33 0.0022
236 DEPRESSION 488 0.0021
237 ASPIRATION 23 0.0021
238 DISABILITY 41 0.0021
239 CONTUSION 199 0.0021
240 GASTROINTESTINAL MOTILITY DISORDER 11 0.0021
241 CARBOHYDRATE ANTIGEN 125 INCREASED 7 0.0021
242 HYPERTENSION 430 0.0020
243 LARGE INTESTINE POLYP 14 0.0020
244 WEIGHT FLUCTUATION 21 0.0020
245 CONSTIPATION 436 0.0020
246 AMNESIA 130 0.0020
247 SUSPECTED OFF LABEL USE 9 0.0020
248 URTICARIA 332 0.0020
249 DYSCHEZIA 6 0.0020
250 ABNORMAL FAECES 16 0.0020
251 WEIGHT INCREASED 435 0.0019
252 ALOPECIA 376 0.0019
253 UNDERDOSE 139 0.0019
254 MATERNAL EXPOSURE BEFORE PREGNANCY 13 0.0019
255 KNEE ARTHROPLASTY 40 0.0019
256 TUMOUR MARKER INCREASED 9 0.0019
257 HEPATIC PAIN 8 0.0019
258 PROTEIN TOTAL DECREASED 7 0.0019
259 PARANASAL SINUS DISCOMFORT 7 0.0018
260 NASOPHARYNGITIS 339 0.0018
261 INSURANCE ISSUE 28 0.0018
262 DIVERTICULUM INTESTINAL 8 0.0018
263 HYPERVOLAEMIA 9 0.0018
264 SPINAL COMPRESSION FRACTURE 15 0.0018
265 LYME DISEASE 6 0.0018
266 HYPERSENSITIVITY 333 0.0018
267 PROSTATOMEGALY 7 0.0018
268 BLOOD CALCIUM DECREASED 20 0.0018
269 PRODUCT USE IN UNAPPROVED INDICATION 440 0.0018
270 FOETAL EXPOSURE DURING PREGNANCY 141 0.0017
271 RENAL FUNCTION TEST ABNORMAL 8 0.0017
272 SERUM FERRITIN INCREASED 9 0.0017
273 ADVERSE DRUG REACTION 153 0.0017
274 ANORECTAL DISCOMFORT 9 0.0017
275 PRODUCT USE ISSUE 313 0.0017
276 ADVERSE EVENT 150 0.0016
277 INSOMNIA 433 0.0016
278 DECREASED APPETITE 377 0.0016
279 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
280 TENDON INJURY 6 0.0016
281 HYPERACUSIS 6 0.0016
282 ASTHENIA 603 0.0016
283 CHRONIC SINUSITIS 6 0.0016
284 IMMUNOSUPPRESSION 14 0.0016
285 FEELING HOT 97 0.0016
286 LIVER DISORDER 70 0.0016
287 EAR INFECTION 42 0.0016
288 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
289 MEDICATION ERROR 87 0.0016
290 GAIT DISTURBANCE 298 0.0016
291 SEASONAL ALLERGY 22 0.0016
292 VASCULAR DEVICE INFECTION 7 0.0015
293 TENDON DISORDER 10 0.0015
294 ELECTROCARDIOGRAM ABNORMAL 12 0.0015
295 NAIL DISCOLOURATION 6 0.0015
296 PLEURISY 9 0.0015
297 MITRAL VALVE INCOMPETENCE 17 0.0015
298 FOREIGN BODY 6 0.0015
299 ANXIETY DISORDER 5 0.0015
300 SKIN PAPILLOMA 6 0.0015
301 FRUSTRATION TOLERANCE DECREASED 12 0.0015
302 STRESS FRACTURE 8 0.0015
303 SPINAL COLUMN STENOSIS 7 0.0015
304 ROAD TRAFFIC ACCIDENT 62 0.0015
305 FACIAL PAIN 13 0.0015
306 NEURALGIA 35 0.0014
307 FEEDING DISORDER 29 0.0014
308 BREATH SOUNDS ABNORMAL 7 0.0014
309 APHTHOUS ULCER 11 0.0014
310 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
311 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
312 SINUSITIS 144 0.0014
313 FLUID INTAKE REDUCED 7 0.0014
314 IMPAIRED GASTRIC EMPTYING 19 0.0014
315 FLATULENCE 79 0.0014
316 ARTHRALGIA 575 0.0014
317 SLEEP APNOEA SYNDROME 26 0.0014
318 DECREASED INTEREST 8 0.0014
319 SENSITIVE SKIN 10 0.0014
320 BACK DISORDER 22 0.0014
321 ILEUS PARALYTIC 6 0.0013
322 CARDIAC DYSFUNCTION 5 0.0013
323 CONDITION AGGRAVATED 408 0.0013
324 MUSCLE ATROPHY 17 0.0013
325 PAIN IN EXTREMITY 395 0.0013
326 RASH 581 0.0013
327 URINARY TRACT DISORDER 6 0.0013
328 POLYARTHRITIS 7 0.0013
329 ADRENAL INSUFFICIENCY 16 0.0013
330 DEVICE RELATED INFECTION 20 0.0013
331 INFECTION 186 0.0013
332 UMBILICAL HERNIA 6 0.0013
333 EPIGASTRIC DISCOMFORT 5 0.0013
334 NONSPECIFIC REACTION 7 0.0013
335 PULMONARY MASS 19 0.0013
336 ARTERIOSCLEROSIS 12 0.0013
337 PULMONARY TOXICITY 9 0.0013
338 PAIN 781 0.0013
339 PROSTATIC DISORDER 7 0.0013
340 BLOOD ALBUMIN DECREASED 10 0.0013
341 TEMPERATURE INTOLERANCE 13 0.0013
342 RENAL CYST 10 0.0013
343 GROIN PAIN 11 0.0013
344 SUBCUTANEOUS ABSCESS 6 0.0013
345 BLEPHARITIS 5 0.0012
346 RHINITIS 10 0.0012
347 ABDOMINAL PAIN 288 0.0012
348 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
349 DIZZINESS 611 0.0012
350 NEUROLOGICAL SYMPTOM 7 0.0012
351 DIARRHOEA 788 0.0012
352 HYPOPHOSPHATAEMIA 9 0.0012
353 HOSPICE CARE 12 0.0012
354 HYPERCALCAEMIA 15 0.0012
355 RESTLESS LEGS SYNDROME 22 0.0012
356 ABDOMINAL TENDERNESS 6 0.0012
357 SKIN WARM 7 0.0012
358 SKIN LACERATION 13 0.0012
359 CHOLECYSTITIS CHRONIC 8 0.0012
360 PNEUMONIA 386 0.0012
361 TENDON PAIN 9 0.0012
362 VOMITING 558 0.0012
363 INFUSION SITE ERYTHEMA 10 0.0012
364 HAEMORRHOIDS 23 0.0012
365 TOOTH ABSCESS 12 0.0012
366 BODY TEMPERATURE INCREASED 24 0.0012
367 JOINT INJURY 25 0.0012
368 HYPERSOMNIA 33 0.0011
369 INGUINAL HERNIA 7 0.0011
370 MALABSORPTION 6 0.0011
371 RECTAL HAEMORRHAGE 49 0.0011
372 FALL 379 0.0011
373 ATELECTASIS 11 0.0011
374 SPINAL OSTEOARTHRITIS 10 0.0011
375 PULMONARY CONGESTION 15 0.0011
376 TUMOUR LYSIS SYNDROME 10 0.0011
377 PIGMENTATION DISORDER 7 0.0011
378 GENERALISED OEDEMA 14 0.0011
379 SCOLIOSIS 7 0.0011
380 PNEUMONIA ASPIRATION 28 0.0011
381 NASAL DRYNESS 7 0.0011
382 BLOOD SODIUM DECREASED 21 0.0011
383 BRUXISM 6 0.0011
384 INFUSION SITE SWELLING 7 0.0011
385 ANAL INCONTINENCE 10 0.0011
386 HEADACHE 697 0.0011
387 MUSCLE TIGHTNESS 18 0.0011
388 BLOOD POTASSIUM INCREASED 18 0.0011
389 GASTROENTERITIS VIRAL 20 0.0011
390 ASTHMA 125 0.0011
391 GASTRIC ULCER 21 0.0011
392 DECUBITUS ULCER 9 0.0011
393 BLOOD POTASSIUM DECREASED 33 0.0011
394 PANCREATITIS 58 0.0011
395 LABORATORY TEST ABNORMAL 32 0.0011
396 GASTRIC ULCER HAEMORRHAGE 6 0.0011
397 FATIGUE 843 0.0011
398 DRY THROAT 11 0.0011
399 CEREBRAL DISORDER 8 0.0011
400 NAUSEA 852 0.0011
401 IMMUNODEFICIENCY 16 0.0011
402 HEAD DISCOMFORT 19 0.0011
403 WEIGHT DECREASED 299 0.0011
404 OCULAR DISCOMFORT 12 0.0011
405 SENSATION OF FOREIGN BODY 9 0.0011
406 FLUID RETENTION 54 0.0011
407 HYPOCALCAEMIA 20 0.0011
408 PARALYSIS 15 0.0010
409 MALAISE 458 0.0010
410 RENAL FAILURE CHRONIC 8 0.0010
411 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
412 ERUCTATION 20 0.0010
413 CONCUSSION 8 0.0010
414 HEREDITARY ANGIOEDEMA 11 0.0010
415 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
416 DYSPNOEA 579 0.0010
417 MULTIPLE ALLERGIES 8 0.0010
418 HEPATIC STEATOSIS 19 0.0010
419 MIDDLE INSOMNIA 19 0.0010
420 VITREOUS FLOATERS 10 0.0010
421 BODY TEMPERATURE DECREASED 10 0.0010
422 SINUS DISORDER 20 0.0010
423 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
424 TRICUSPID VALVE INCOMPETENCE 8 0.0010
425 CYSTITIS 32 0.0010
426 OEDEMA PERIPHERAL 122 0.0010
427 CARPAL TUNNEL SYNDROME 14 0.0010
428 TOOTH FRACTURE 11 0.0010
429 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
430 NODULE 13 0.0010
431 NOCTURIA 12 0.0010
432 NEUROPATHY PERIPHERAL 94 0.0010
433 MUSCLE DISORDER 8 0.0010
434 CHEST PAIN 182 0.0010
435 DYSPNOEA EXERTIONAL 37 0.0010
436 INCREASED TENDENCY TO BRUISE 9 0.0010
437 SMALL INTESTINAL OBSTRUCTION 12 0.0010
438 TENDON RUPTURE 12 0.0010
439 HYPOTHYROIDISM 31 0.0010
440 LIMB DISCOMFORT 30 0.0010
441 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
442 COLD SWEAT 17 0.0010
443 FAILURE TO THRIVE 5 0.0010
444 VENTRICULAR EXTRASYSTOLES 10 0.0010
445 SINUS CONGESTION 13 0.0010
446 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
447 APATHY 14 0.0010
448 URINARY RETENTION 32 0.0010
449 SWELLING OF EYELID 6 0.0010
450 DERMATITIS ALLERGIC 12 0.0010
451 VISUAL IMPAIRMENT 117 0.0009
452 RENAL PAIN 10 0.0009
453 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
454 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
455 ANXIETY 267 0.0009
456 PROCTALGIA 6 0.0009
457 COORDINATION ABNORMAL 13 0.0009
458 ECONOMIC PROBLEM 14 0.0009
459 ERYTHEMA OF EYELID 5 0.0009
460 PYELONEPHRITIS 8 0.0009
461 VITAMIN D DEFICIENCY 9 0.0009
462 BLOOD PRESSURE FLUCTUATION 22 0.0009
463 HOT FLUSH 69 0.0009
464 THERAPY CHANGE 9 0.0009
465 PROCEDURAL COMPLICATION 7 0.0009
466 GASTRITIS 24 0.0009
467 PRODUCT FORMULATION ISSUE 6 0.0009
468 MUSCULOSKELETAL CHEST PAIN 14 0.0009
469 CYSTIC FIBROSIS 5 0.0009
470 DIVERTICULITIS 25 0.0009
471 NO THERAPEUTIC RESPONSE 11 0.0009
472 CARDIAC FAILURE ACUTE 6 0.0009
473 SPINAL FRACTURE 18 0.0009
474 OFF LABEL USE 779 0.0009
475 HEART RATE IRREGULAR 20 0.0009
476 FURUNCLE 7 0.0009
477 CHOLECYSTITIS ACUTE 5 0.0009
478 GINGIVAL PAIN 7 0.0009
479 GINGIVAL BLEEDING 12 0.0009
480 SCAB 10 0.0009
481 MICTURITION URGENCY 10 0.0009
482 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
483 LYMPHOEDEMA 6 0.0009
484 LARGE INTESTINE PERFORATION 6 0.0009
485 HYPERTRANSAMINASAEMIA 6 0.0009
486 URINARY TRACT INFECTION 147 0.0009
487 POST PROCEDURAL INFECTION 7 0.0009
488 POLYURIA 7 0.0009
489 FLANK PAIN 8 0.0009
490 NASAL CONGESTION 50 0.0008
491 HIATUS HERNIA 11 0.0008
492 VENTRICULAR TACHYCARDIA 14 0.0008
493 ENERGY INCREASED 5 0.0008
494 PLATELET COUNT INCREASED 11 0.0008
495 BODY HEIGHT DECREASED 9 0.0008
496 TENDONITIS 13 0.0008
497 LUNG INFECTION 13 0.0008
498 CANDIDA INFECTION 14 0.0008
499 LEUKOCYTOSIS 15 0.0008
500 CORONARY ARTERY DISEASE 25 0.0008
501 DIZZINESS POSTURAL 8 0.0008
502 BRONCHITIS 61 0.0008
503 DYSSTASIA 24 0.0008
504 EYE DISORDER 27 0.0008
505 PSEUDOMONAS INFECTION 7 0.0008
506 MUSCLE SPASTICITY 10 0.0008
507 PRODUCT TASTE ABNORMAL 11 0.0008
508 PALPITATIONS 95 0.0008
509 INTENTIONAL DOSE OMISSION 23 0.0008
510 CYST 10 0.0008
511 RED BLOOD CELL COUNT DECREASED 23 0.0008
512 ARRHYTHMIA 38 0.0008
513 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
514 SKIN INFECTION 9 0.0008
515 INTESTINAL PERFORATION 9 0.0008
516 OVARIAN CYST 8 0.0008
517 EYE INFECTION 9 0.0008
518 OSTEOPENIA 12 0.0008
519 CHRONIC KIDNEY DISEASE 60 0.0008
520 HUNGER 11 0.0008
521 DYSURIA 29 0.0008
522 MOOD SWINGS 25 0.0008
523 HYPOPHAGIA 20 0.0008
524 THROAT IRRITATION 35 0.0008
525 PAIN IN JAW 22 0.0008
526 ATRIOVENTRICULAR BLOCK 6 0.0008
527 INFUSION SITE PAIN 10 0.0008
528 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
529 ELECTROLYTE IMBALANCE 9 0.0008
530 PYREXIA 268 0.0008
531 DELUSION 12 0.0008
532 ANGER 26 0.0008
533 BONE DISORDER 14 0.0008
534 BONE PAIN 45 0.0008
535 RESPIRATORY TRACT INFECTION 20 0.0008
536 END STAGE RENAL DISEASE 14 0.0008
537 LETHARGY 44 0.0008
538 DEHYDRATION 102 0.0008
539 AFFECTIVE DISORDER 6 0.0008
540 COLITIS ULCERATIVE 34 0.0008
541 NERVE COMPRESSION 7 0.0008
542 BACTERAEMIA 9 0.0008
543 INCONTINENCE 8 0.0008
544 PRODUCT DISTRIBUTION ISSUE 7 0.0008
545 BLOOD PRESSURE ABNORMAL 15 0.0008
546 FEELING COLD 21 0.0008
547 ULCER 12 0.0008
548 HYPERLIPIDAEMIA 9 0.0008
549 BLOOD PRESSURE INCREASED 115 0.0008
550 ATRIAL FLUTTER 6 0.0008
551 ASCITES 22 0.0007
552 SENSORY LOSS 6 0.0007
553 FULL BLOOD COUNT DECREASED 15 0.0007
554 INTESTINAL OBSTRUCTION 28 0.0007
555 SYNCOPE 74 0.0007
556 FOOT FRACTURE 14 0.0007
557 VERTIGO 45 0.0007
558 HYPOKALAEMIA 34 0.0007
559 LYMPHOCYTE COUNT DECREASED 13 0.0007
560 ABNORMAL LOSS OF WEIGHT 5 0.0007
561 OESOPHAGITIS 8 0.0007
562 BACK PAIN 170 0.0007
563 ECCHYMOSIS 5 0.0007
564 ACUTE RESPIRATORY FAILURE 14 0.0007
565 PHOTOSENSITIVITY REACTION 12 0.0007
566 ILEUS 9 0.0007
567 HERNIA 14 0.0007
568 OROPHARYNGEAL PAIN 67 0.0007
569 HAIR GROWTH ABNORMAL 5 0.0007
570 ILLNESS 74 0.0007
571 MALNUTRITION 8 0.0007
572 FEBRILE NEUTROPENIA 47 0.0007
573 NERVOUSNESS 37 0.0007
574 EATING DISORDER 15 0.0007
575 SINUS TACHYCARDIA 10 0.0007
576 DIVERTICULUM 5 0.0007
577 THROAT TIGHTNESS 19 0.0007
578 VITAMIN D DECREASED 6 0.0007
579 DRY EYE 35 0.0007
580 CHOLECYSTECTOMY 8 0.0007
581 SEPSIS 78 0.0007
582 PREGNANCY 14 0.0007
583 MUSCULOSKELETAL DISCOMFORT 12 0.0007
584 POLLAKIURIA 29 0.0007
585 MUSCLE STRAIN 6 0.0007
586 CARDIAC MURMUR 6 0.0007
587 ORTHOSTATIC HYPOTENSION 12 0.0007
588 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
589 MOTOR DYSFUNCTION 7 0.0007
590 TACHYCARDIA 61 0.0007
591 MOVEMENT DISORDER 22 0.0007
592 EYE PRURITUS 23 0.0007
593 SPLENOMEGALY 8 0.0007
594 BALANCE DISORDER 59 0.0007
595 INITIAL INSOMNIA 7 0.0007
596 EAR DISCOMFORT 7 0.0007
597 RIB FRACTURE 14 0.0007
598 NEPHROLITHIASIS 31 0.0007
599 URINARY INCONTINENCE 20 0.0007
600 HYPONATRAEMIA 38 0.0007
601 TOOTH DISORDER 15 0.0007
602 FEELING DRUNK 5 0.0007
603 PULMONARY HYPERTENSION 14 0.0007
604 GASTRIC DISORDER 23 0.0007
605 FEELING ABNORMAL 160 0.0007
606 ATRIAL FIBRILLATION 65 0.0007
607 HOSPITALISATION 102 0.0007
608 VIRAL INFECTION 22 0.0007
609 TREATMENT NONCOMPLIANCE 36 0.0007
610 SKIN LESION 18 0.0007
611 HEART RATE INCREASED 65 0.0007
612 ACCIDENTAL OVERDOSE 24 0.0007
613 EYE PAIN 37 0.0007
614 IMPAIRED WORK ABILITY 14 0.0007
615 TINNITUS 30 0.0007
616 RETINAL DETACHMENT 6 0.0007
617 MUSCLE TWITCHING 15 0.0007
618 CARDIOMEGALY 8 0.0006
619 RHINORRHOEA 42 0.0006
620 PRODUCTIVE COUGH 31 0.0006
621 DECREASED ACTIVITY 7 0.0006
622 FOOD ALLERGY 5 0.0006
623 BLOOD PRESSURE DECREASED 43 0.0006
624 ANHEDONIA 17 0.0006
625 HYPOMAGNESAEMIA 9 0.0006
626 ANKLE FRACTURE 10 0.0006
627 FAECES DISCOLOURED 14 0.0006
628 WITHDRAWAL SYNDROME 27 0.0006
629 COGNITIVE DISORDER 30 0.0006
630 ASPARTATE AMINOTRANSFERASE INCREASED 34 0.0006
631 PHOTOPHOBIA 12 0.0006
632 LACERATION 6 0.0006
633 PRODUCT USE COMPLAINT 10 0.0006
634 DENTAL CARIES 7 0.0006
635 DISTURBANCE IN ATTENTION 34 0.0006
636 RESPIRATORY TRACT CONGESTION 10 0.0006
637 RASH PRURITIC 34 0.0006
638 ROTATOR CUFF SYNDROME 8 0.0006
639 SINUS BRADYCARDIA 6 0.0006
640 SKIN ULCER 16 0.0006
641 DYSPHONIA 36 0.0006
642 KIDNEY INFECTION 12 0.0006
643 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
644 HEPATOMEGALY 6 0.0006
645 HERPES ZOSTER 35 0.0006
646 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
647 BEDRIDDEN 8 0.0006
648 LIGAMENT SPRAIN 6 0.0006
649 STAPHYLOCOCCAL INFECTION 20 0.0006
650 INABILITY TO AFFORD MEDICATION 6 0.0006
651 EMBOLISM 5 0.0006
652 BURNING SENSATION 42 0.0006
653 HEART RATE DECREASED 21 0.0006
654 ARTHRITIS 47 0.0006
655 VISION BLURRED 82 0.0006
656 HYPOAESTHESIA ORAL 9 0.0006
657 FEAR 16 0.0006
658 DRUG INEFFECTIVE 783 0.0006
659 HAEMATEMESIS 15 0.0006
660 MELAENA 13 0.0006
661 DYSPHAGIA 56 0.0006
662 HYPERHIDROSIS 76 0.0006
663 EUPHORIC MOOD 6 0.0006
664 PRURITUS 225 0.0006
665 SCAR 10 0.0006
666 THYROID DISORDER 9 0.0006
667 EMOTIONAL DISORDER 18 0.0006
668 PERIPHERAL COLDNESS 8 0.0006
669 INTENTIONAL PRODUCT MISUSE 51 0.0006
670 PARANOIA 10 0.0006
671 RASH PAPULAR 13 0.0006
672 SUICIDAL IDEATION 53 0.0006
673 PROTEINURIA 11 0.0006
674 EYE DISCHARGE 6 0.0006
675 PANIC ATTACK 21 0.0006
676 PRESYNCOPE 14 0.0006
677 PRODUCT SUBSTITUTION ISSUE 33 0.0006
678 PANCYTOPENIA 32 0.0006
679 SOMNOLENCE 115 0.0006
680 HALLUCINATION 43 0.0006
681 BLOOD CALCIUM INCREASED 5 0.0006
682 FULL BLOOD COUNT ABNORMAL 6 0.0006
683 LYMPHADENOPATHY 20 0.0006
684 ORAL HERPES 11 0.0006
685 BREAST PAIN 6 0.0006
686 AGGRESSION 28 0.0006
687 RENAL DISORDER 26 0.0006
688 HAEMARTHROSIS 5 0.0006
689 GASTROINTESTINAL INFECTION 5 0.0006
690 GOUT 10 0.0006
691 PAIN OF SKIN 15 0.0006
692 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
693 CELLULITIS 28 0.0006
694 BLOOD BILIRUBIN INCREASED 15 0.0006
695 UNEVALUABLE EVENT 42 0.0006
696 HAEMATOCRIT DECREASED 11 0.0006
697 HYPOKINESIA 8 0.0006
698 PELVIC PAIN 10 0.0005
699 GASTROENTERITIS 8 0.0005
700 SURGERY 32 0.0005
701 RASH ERYTHEMATOUS 26 0.0005
702 MYALGIA 92 0.0005
703 PROCEDURAL PAIN 15 0.0005
704 PRODUCT DOSE OMISSION ISSUE 159 0.0005
705 VENTRICULAR FIBRILLATION 6 0.0005
706 NEUTROPHIL COUNT DECREASED 22 0.0005
707 NERVE INJURY 6 0.0005
708 CONJUNCTIVITIS 10 0.0005
709 HAEMOPTYSIS 15 0.0005
710 BACTERIAL INFECTION 10 0.0005
711 DIARRHOEA HAEMORRHAGIC 5 0.0005
712 PLATELET COUNT DECREASED 57 0.0005
713 OXYGEN SATURATION DECREASED 30 0.0005
714 ORAL CANDIDIASIS 7 0.0005
715 COUGH 149 0.0005
716 DYSARTHRIA 20 0.0005
717 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
718 SARS-COV-2 TEST POSITIVE 7 0.0005
719 DEPRESSED MOOD 28 0.0005
720 LACRIMATION INCREASED 16 0.0005
721 ANAEMIA 101 0.0005
722 SEPTIC SHOCK 23 0.0005
723 IMPAIRED DRIVING ABILITY 6 0.0005
724 BLOOD COUNT ABNORMAL 8 0.0005
725 OCULAR HYPERAEMIA 25 0.0005
726 THERAPY CESSATION 27 0.0005
727 DERMATITIS 11 0.0005
728 DYSGEUSIA 39 0.0005
729 INCREASED APPETITE 10 0.0005
730 MOUTH ULCERATION 11 0.0005
731 EPISTAXIS 39 0.0005
732 POST PROCEDURAL COMPLICATION 10 0.0005
733 CHILLS 61 0.0005
734 INFLUENZA 58 0.0005
735 COVID-19 91 0.0005
736 MADAROSIS 6 0.0005
737 RASH MACULAR 18 0.0005
738 ABDOMINAL PAIN LOWER 13 0.0005
739 BASAL CELL CARCINOMA 8 0.0005
740 DEEP VEIN THROMBOSIS 33 0.0005
741 DEVICE LEAKAGE 22 0.0005
742 HEAD INJURY 16 0.0005
743 PNEUMOTHORAX 8 0.0005
744 GALLBLADDER DISORDER 9 0.0005
745 EYE IRRITATION 29 0.0005
746 MACULAR DEGENERATION 6 0.0005
747 MUSCLE RIGIDITY 6 0.0005
748 SKIN DISCOLOURATION 23 0.0005
749 RENAL IMPAIRMENT 42 0.0005
750 BLOOD TEST ABNORMAL 7 0.0005
751 APHASIA 15 0.0005
752 EMPHYSEMA 5 0.0005
753 MENTAL IMPAIRMENT 12 0.0005
754 TREMOR 82 0.0005
755 EYELID PTOSIS 5 0.0005
756 NIGHTMARE 17 0.0005
757 BLOOD CREATININE INCREASED 32 0.0005
758 ACUTE KIDNEY INJURY 75 0.0005
759 THERAPY INTERRUPTED 35 0.0005
760 HAEMATOCHEZIA 27 0.0005
761 NEOPLASM PROGRESSION 17 0.0005
762 HYPOTENSION 98 0.0005
763 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
764 SPINAL OPERATION 6 0.0005
765 CATARACT 29 0.0005
766 MANIA 8 0.0005
767 PHARYNGITIS 6 0.0005
768 COMA 23 0.0005
769 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
770 FLUID OVERLOAD 7 0.0005
771 SECRETION DISCHARGE 6 0.0005
772 CHEST DISCOMFORT 49 0.0005
773 BLOOD URINE PRESENT 9 0.0005
774 HALLUCINATION, VISUAL 10 0.0005
775 MUSCULOSKELETAL DISORDER 9 0.0005
776 FEELING JITTERY 9 0.0005
777 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
778 RENAL INJURY 14 0.0005
779 GLAUCOMA 9 0.0005
780 RESPIRATORY FAILURE 34 0.0005
781 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
782 POOR QUALITY SLEEP 10 0.0005
783 OVERDOSE 100 0.0005
784 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
785 CARDIAC FAILURE CONGESTIVE 37 0.0005
786 BIPOLAR DISORDER 5 0.0005
787 LEUKOPENIA 23 0.0005
788 CHOLELITHIASIS 15 0.0005
789 ALANINE AMINOTRANSFERASE INCREASED 28 0.0005
790 IMMUNE SYSTEM DISORDER 6 0.0005
791 TOOTH INFECTION 6 0.0005
792 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
793 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
794 FUNGAL INFECTION 15 0.0004
795 CYTOKINE RELEASE SYNDROME 9 0.0004
796 COLITIS 17 0.0004
797 INJECTION SITE URTICARIA 11 0.0004
798 THIRST 8 0.0004
799 RENAL FAILURE ACUTE 19 0.0004
800 SNEEZING 10 0.0004
801 SWELLING FACE 29 0.0004
802 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
803 TOOTHACHE 8 0.0004
804 DISEASE RECURRENCE 21 0.0004
805 MOOD ALTERED 12 0.0004
806 HAEMATURIA 15 0.0004
807 LOSS OF CONSCIOUSNESS 56 0.0004
808 SENSORY DISTURBANCE 7 0.0004
809 PLASMA CELL MYELOMA 17 0.0004
810 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
811 SEIZURE 50 0.0004
812 PERICARDIAL EFFUSION 10 0.0004
813 MENTAL STATUS CHANGES 12 0.0004
814 DISEASE PROGRESSION 51 0.0004
815 EYELID OEDEMA 5 0.0004
816 APHONIA 6 0.0004
817 THINKING ABNORMAL 8 0.0004
818 MASS 6 0.0004
819 DISORIENTATION 17 0.0004
820 HAEMOGLOBIN DECREASED 44 0.0004
821 PLEURAL EFFUSION 26 0.0004
822 UNRESPONSIVE TO STIMULI 11 0.0004
823 MULTIPLE FRACTURES 7 0.0004
824 DIPLOPIA 11 0.0004
825 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 76 0.0004
826 BLOOD IRON DECREASED 5 0.0004
827 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
828 THROMBOCYTOPENIA 47 0.0004
829 SKIN DISORDER 14 0.0004
830 NERVOUS SYSTEM DISORDER 13 0.0004
831 PRURITUS GENERALISED 9 0.0004
832 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
833 IRRITABILITY 25 0.0004
834 CRYING 15 0.0004
835 HYPERGLYCAEMIA 15 0.0004
836 ENCEPHALOPATHY 10 0.0004
837 SKIN HAEMORRHAGE 6 0.0004
838 ABNORMAL WEIGHT GAIN 5 0.0004
839 ORAL PAIN 9 0.0004
840 INJECTION SITE BRUISING 32 0.0004
841 AMENORRHOEA 7 0.0004
842 RENAL FAILURE 53 0.0004
843 PRODUCT DOSE OMISSION 26 0.0004
844 METASTASES TO LIVER 7 0.0004
845 HYPOXIA 14 0.0004
846 THERAPEUTIC RESPONSE DECREASED 24 0.0004
847 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
848 DRUG ERUPTION 7 0.0004
849 ERYTHEMA 81 0.0004
850 DYSKINESIA 16 0.0004
851 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
852 PHARYNGEAL OEDEMA 6 0.0004
853 HAEMATOMA 10 0.0004
854 PRODUCT PRESCRIBING ERROR 9 0.0004
855 DYSMENORRHOEA 5 0.0004
856 EYE SWELLING 14 0.0004
857 ABSCESS 6 0.0004
858 CARDIAC DISORDER 35 0.0004
859 FLUSHING 38 0.0004
860 SKIN CANCER 8 0.0004
861 AGITATION 27 0.0004
862 INFLUENZA LIKE ILLNESS 30 0.0004
863 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
864 OSTEONECROSIS OF JAW 9 0.0004
865 APPLICATION SITE PAIN 8 0.0004
866 ECZEMA 19 0.0004
867 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
868 AGEUSIA 9 0.0004
869 CHOKING 7 0.0004
870 SKIN FISSURES 7 0.0004
871 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
872 MULTIPLE SCLEROSIS 17 0.0004
873 FEMUR FRACTURE 11 0.0004
874 CARDIOVASCULAR DISORDER 9 0.0004
875 CHROMATURIA 8 0.0004
876 SWOLLEN TONGUE 11 0.0004
877 DRY SKIN 47 0.0004
878 ERECTILE DYSFUNCTION 9 0.0004
879 ANGINA PECTORIS 10 0.0003
880 HYPOACUSIS 15 0.0003
881 NO ADVERSE EVENT 63 0.0003
882 EMOTIONAL DISTRESS 42 0.0003
883 ANOSMIA 5 0.0003
884 PSORIASIS 45 0.0003
885 MUCOSAL INFLAMMATION 9 0.0003
886 SEDATION 9 0.0003
887 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
888 SYRINGE ISSUE 6 0.0003
889 HIP FRACTURE 11 0.0003
890 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
891 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
892 COLON CANCER 5 0.0003
893 BONE LOSS 5 0.0003
894 OSTEOMYELITIS 6 0.0003
895 LOCALISED INFECTION 8 0.0003
896 PALLOR 9 0.0003
897 INTERSTITIAL LUNG DISEASE 16 0.0003
898 LIP SWELLING 11 0.0003
899 RETCHING 7 0.0003
900 DIABETES MELLITUS 25 0.0003
901 RESTLESSNESS 12 0.0003
902 RESPIRATORY DISTRESS 9 0.0003
903 ABNORMAL DREAMS 9 0.0003
904 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
905 SPEECH DISORDER 17 0.0003
906 ABASIA 8 0.0003
907 EJECTION FRACTION DECREASED 5 0.0003
908 CYANOSIS 5 0.0003
909 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
910 NEUTROPENIA 43 0.0003
911 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
912 DRUG INTERACTION 50 0.0003
913 HYPERKALAEMIA 11 0.0003
914 BLOOD GLUCOSE DECREASED 15 0.0003
915 RHABDOMYOLYSIS 13 0.0003
916 PSYCHOTIC DISORDER 9 0.0003
917 ABNORMAL BEHAVIOUR 12 0.0003
918 CARDIAC ARREST 25 0.0003
919 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
920 DRUG LEVEL INCREASED 5 0.0003
921 BLOOD UREA INCREASED 5 0.0003
922 THROMBOSIS 24 0.0003
923 PRODUCT PHYSICAL ISSUE 6 0.0003
924 SKIN EXFOLIATION 25 0.0003
925 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
926 HEMIPARESIS 5 0.0003
927 PNEUMONITIS 8 0.0003
928 INJECTION SITE RASH 9 0.0003
929 ACNE 22 0.0003
930 CARDIO-RESPIRATORY ARREST 12 0.0003
931 DEVICE MALFUNCTION 20 0.0003
932 SKIN BURNING SENSATION 20 0.0003
933 PRODUCT PRESCRIBING ISSUE 6 0.0003
934 CARDIAC FAILURE 22 0.0003
935 PULMONARY EMBOLISM 26 0.0003
936 STEVENS-JOHNSON SYNDROME 6 0.0003
937 PANCREATITIS ACUTE 6 0.0003
938 APPLICATION SITE PRURITUS 6 0.0003
939 FRACTURE 5 0.0003
940 BRADYCARDIA 14 0.0003
941 PRODUCT AVAILABILITY ISSUE 6 0.0003
942 INCORRECT DOSE ADMINISTERED 60 0.0003
943 DRUG WITHDRAWAL SYNDROME 23 0.0003
944 BONE DENSITY DECREASED 8 0.0003
945 RESPIRATORY ARREST 7 0.0003
946 INJECTION SITE PRURITUS 17 0.0003
947 DEMENTIA 7 0.0003
948 INJECTION SITE ERYTHEMA 31 0.0002
949 HAEMORRHAGE 26 0.0002
950 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
951 HYPOGLYCAEMIA 12 0.0002
952 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
953 PULMONARY OEDEMA 11 0.0002
954 LIVER FUNCTION TEST ABNORMAL 7 0.0002
955 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
956 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
957 APPLICATION SITE ERYTHEMA 6 0.0002
958 CEREBRAL HAEMORRHAGE 8 0.0002
959 INJECTION SITE SWELLING 17 0.0002
960 LIMB INJURY 6 0.0002
961 CEREBROVASCULAR ACCIDENT 37 0.0002
962 DEATH 186 0.0002
963 INJECTION SITE HAEMORRHAGE 17 0.0002
964 DEVICE ISSUE 19 0.0002
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
966 NEOPLASM MALIGNANT 14 0.0002
967 ACUTE MYOCARDIAL INFARCTION 6 0.0002
968 BLOOD GLUCOSE INCREASED 38 0.0002
969 ANAPHYLACTIC REACTION 11 0.0002
970 EXTRA DOSE ADMINISTERED 8 0.0002
971 DEAFNESS 5 0.0002
972 INJECTION SITE MASS 7 0.0002
973 INJECTION SITE PAIN 57 0.0002
974 MENTAL DISORDER 8 0.0002
975 MYOCARDIAL INFARCTION 32 0.0002
976 EXPIRED PRODUCT ADMINISTERED 6 0.0002
977 SKIN IRRITATION 8 0.0002
978 DRUG DEPENDENCE 28 0.0002
979 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
980 DERMATITIS ATOPIC 9 0.0002
981 PRODUCT ADHESION ISSUE 6 0.0002
982 DEVICE DISLOCATION 7 0.0002
983 DRUG DOSE OMISSION 23 0.0001
984 PRODUCT STORAGE ERROR 12 0.0001
985 ABORTION SPONTANEOUS 5 0.0001
986 DEVICE BREAKAGE 5 0.0001
987 BLINDNESS 5 0.0001
988 TOXICITY TO VARIOUS AGENTS 19 0.0001
989 DRUG EFFECT DECREASED 6 0.0001
990 SUICIDE ATTEMPT 6 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
992 BREAST CANCER 9 0.0001
993 INTENTIONAL OVERDOSE 6 0.0001